−21.7
Aptevo Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−21.0
FY23:
−11.7
FY24:
−23.8
FY25:
−25.6
Change from FY21 to FY25
millions USD
FY21:
−0.71
FY22:
−0.03
FY23:
0
FY24:
0
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
26.2
FY22:
−2.62
FY23:
6.00
FY24:
15.6
FY25:
38.5
millions USD
FY21:
3.77
FY22:
−23.7
FY23:
−5.73
FY24:
−8.19
FY25:
12.9
(positive)
Change from FY21 to FY22
millions USD
FY21:
−22.4
FY22:
−21.1
FY23:
–
FY24:
–
FY25:
–
All amounts in millions USD